HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Mullen Selected Research

Daniel Mullen Research Topics

Disease

2Lymphopenia (Lymphocytopenia)
11/2018 - 01/2018
2Cardiotoxicity
01/2018 - 01/2017
2Neoplasms (Cancer)
04/2017 - 09/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2017 - 01/2017
1Squamous Cell Neoplasms (Squamous Cell Cancer)
11/2018
1Glioblastoma (Glioblastoma Multiforme)
01/2018
1Brain Neoplasms (Brain Tumor)
10/2017
1Melanoma (Melanoma, Malignant)
10/2017
1Vulvar Neoplasms (Vulvar Cancer)
04/2017
1Lung Neoplasms (Lung Cancer)
01/2017
1Adenocarcinoma of Lung
01/2017

Drug/Important Bio-Agent (IBA)

1Biomarkers (Surrogate Marker)IBA
11/2018
1Temozolomide (Temodar)FDA LinkGeneric
01/2018
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1p21(ras) farnesyl-protein transferase (protein farnesyltransferase)IBA
09/2008

Therapy/Procedure

5Radiotherapy
11/2018 - 01/2017
2Chemoradiotherapy
01/2018 - 01/2017
1Immunotherapy
10/2017
1Therapeutics
10/2017
1Brachytherapy
04/2017